KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001366244-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 13, 2026 |
| Document Date | Feb 11, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
17,594
Total Value
$52,657.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Feb 11, 2026 | Exercise/Conversion | 7,120 | โ | โ | 431,640 | Direct | โ | View Details | |
Director | Common Stock | โ | Feb 12, 2026 | Sale | 3,354 | $15.70 | $52,657.80 | 428,286 | Direct | โ | View Details | |
Director | Restricted Stock Unit | Derivative | Feb 11, 2026 | Exercise/Conversion | 7,120 | $0.00 | $0.00 | 99,680 | Direct | โ | View Details |